Reference | 1: Araki N, Tsuruoka S, Hasegawa G, Yanagihara H, Omasa T, Enosawa S, Yamazoe Y,
Fujimura A. Inhibition of CYP3A4 by 6/’,7/’-dihydroxybergamottin in human CYP3A4
over-expressed hepG2 cells. J Pharm Pharmacol. 2012 Dec;64(12):1715-21. doi:
10.1111/j.2042-7158.2012.01562.x. Epub 2012 Aug 2. PubMed PMID: 23146034.
<br>
2: Myung K, Manthey JA, Narciso JA. Biotransformations of
6/’,7/’-dihydroxybergamottin and 6/’,7/’-epoxybergamottin by the citrus-pathogenic
fungi diminish cytochrome P450 3A4 inhibitory activity. Bioorg Med Chem Lett.
2012 Mar 15;22(6):2279-82. doi: 10.1016/j.bmcl.2012.01.081. Epub 2012 Jan 30.
PubMed PMID: 22342630.
<br>
3: Ishihara M, Toda H, Sunagane N, Ohta T. [Furanocoumarins contents and
cytochrome P450 3A (CYP3A) inhibitory activities of various processed fruit peel
products: outflow of 6/’,7/’-Dihydroxybergamottin during processing treatment of
peel]. Yakugaku Zasshi. 2011;131(5):679-84. Japanese. PubMed PMID: 21532264.
<br>
4: Edwards DJ, Fitzsimmons ME, Schuetz EG, Yasuda K, Ducharme MP, Warbasse LH,
Woster PM, Schuetz JD, Watkins P. 6/’,7/’-Dihydroxybergamottin in grapefruit juice
and Seville orange juice: effects on cyclosporine disposition, enterocyte CYP3A4,
and P-glycoprotein. Clin Pharmacol Ther. 1999 Mar;65(3):237-44. PubMed PMID:
10096255.
<br>
5: Bailey DG, Kreeft JH, Munoz C, Freeman DJ, Bend JR. Grapefruit
juice-felodipine interaction: effect of naringin and 6/’,7/’-dihydroxybergamottin
in humans. Clin Pharmacol Ther. 1998 Sep;64(3):248-56. PubMed PMID: 9757148.
<br>
6: Edwards DJ, Bellevue FH 3rd, Woster PM. Identification of
6/’,7/’-dihydroxybergamottin, a cytochrome P450 inhibitor, in grapefruit juice.
Drug Metab Dispos. 1996 Dec;24(12):1287-90. PubMed PMID: 8971132.
|